Quinapril in patients with congestive heart failure: Controlled trial versus captopril

American Journal of Therapeutics

Volumn 4, Issue 5-6, 1997, Pages 181-188

  Acanfora, Domenico ^a   Furgi, Giuseppe ^a   Trojano, Luigi ^a   Picone, Costantino ^a   Iannuzzi, Gian Luca ^b   Rossi, Michele ^a   Papa, Antimo ^c   Rengo, Carlo ^b   Rengo, Franco ^a,b  

^a IRCCS   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Rehabilitation Institute of Campoli del Monte Taburno ^*

Author keywords

Captopril; Congestive heart failure; Exercise capacity; Left ventricular ejection fraction; Quinapril

Indexed keywords

CAPTOPRIL; QUINAPRIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DRUG EFFICACY; DRUG SCREENING; EXERCISE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TASTE DISORDER; UNSTABLE ANGINA PECTORIS;

EID: 0030940230     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-199705000-00004     Document Type: Article

References (41)

1. Griffiths BE, Penny WI, Lewis MI, Henderson AH: Maintenance of the inotropic effect of digoxin on long-term treatment. Br Med J 1982;284:1819-1822.
2. Lee DC, Johnson RA, Bingham JB: Heart failure in outpatients: a randomized trial of digoxin vs placebo. N Engl J Med 1982;306:699.
3. Dobbs SM, Kenyon WL, Dobbs RJ: Maintenance digoxin after an episode of heart failure: placebo-controlled trial in outpatients. Br Med J 1977;1:749-752.
4. Cohn JN, Archibald DG, Ziesche S, et al.: Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med 1986;314:1547-1552.
5. Cohn JN, Johnson G, Ziesche S, et al.: A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303-310.
6. Packer M, Lee WH, Yushak M, Medina N: Comparison of captopril and enalapril in patients with severe chronic heart failure. N Engl J Med 1986;315:847-853.
7. Hughes CV, Wong M, Johnson G, Cohn JN: Influence of age and mechanisms and prognosis of heart failure. Circulation 1993;87(Suppl VI):VI-111-VI-117.
8. Cody RJ: Hemodynamic responses to specific renin angiotensin inhibitors in hypertension and heart failure: a review. Drugs 1984;26:144-169.
9. Curtiss C, Cohn JN, Vrobel T, Franciosa JA: Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure. Circulation 1978; 58:763-770.
10. Parmley WW: Pathophysiology and current therapy of congestive heart failure. J Am Coll Cardiol 1989;13:771-778.
11. Carter-Grinstead W, Young JB: The myocardial renin-angiotensin system: existence, importance, and clinical implications. Am Heart J 1992;123:1039-1045.
12. Hirsch AT, Pinto YM, Schunkert H, Dzau VJ: Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure. Am J Cardiol 1990;66:22D-32D.
13. Hirsch AT, Talsness CE, Schunkert H, Paul M, Dzau VJ: Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res 1991; 69:475-482.
14. Rengo F, Acanfora D, Furgi G, et al.: Comparison of the safety and efficacy of delapril with enalapril in patients with congestive heart failure. Am J Cardiol 1995;75:25F-28F.
15. Acanfora D, Lanzillo T, Papa A, et al.: Congestive heart failure in elderly patients: controlled study of delapril versus captopril. Am J Cardiol 1995;75:37F-43F.
16. Furberg CD, Yusuf S: Effects of vasodilators on survival in chronic congestive heart failure. Am J Cardiol 1985; 55:1110-1113.
17. Fabris B, Bingzhong C, Pupic V, Perich R, Johnston CI: Inhibition of angiotensin-converting enzyme (ACE) in plasma and tissue. J Cardiovasc Pharmacol 1990;15 (Suppl 2):S6-S16.
18. Kaplan HR, Taylor DG, Olson DG, Andrews LW: Quinapril: a preclinical review of the pharmacology, pharmacokinetics and toxicology. Angiology 1989;40: 335-349.
19. Johnston CI, Fabris B, Yamada H, et al.: Comparative studies of tissue inhibition by angiotensin converting enzyme inhibitors. J Hypertens 1989;7(Suppl 5):S11-S16.
20. Holt P, Majim J, Sowton E: The acute hemodynamic effect of quinapril, a new non-sulphydryl angiotensin converting enzyme inhibitor in patients with severe congestive cardiac failure. Eur J Clin Pharmacol 1986;31:9-14.
21. Kinoshita A, Urata H, Bumpus FM, Husain A: Measurement of angiotensin I converting enzyme inhibition in the heart. Circ Res 1993;73:51-60.
22. Olson SC, Horvath AM, Michniewicxz BD, et al.: The clinical pharmacokinetics of quinapril. Angiology 1989; 40:335-349.
23. Sahn DJ, De Maria A, Kisslo J, et al.: The Committee on M-mode Standardization of the American Society of Echocardiography. Recommendations regarding quantification in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1081.
24. Aronow WS, Ahn C, Kronzon I: Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated with coronary artery disease. Am J Cardiol 1990;15:1257-1259.
25. Giles TD, Katz R, Sullivan JM, et al.: Short- and long-acting angiotensin-converting enzyme inhibitors: A randomized trial of lisinopril versus captopril in the treatment of congestive heart failure. J Am Coll Cardiol 1989; 13:1240-1247.
26. Chatterjee K, Parmley WW, Cohn JN, et al.: A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response. Am Heart J 1985;110(Suppl 2):439-447.
27. Ader R, Chatterjee K, Ports T, et al.: Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor. Circulation 1980;61:931-937.
28. Levine TB, Franciosa JA, Cohn JN: Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure. Circulation 1980;62:35-41.
29. Captopril Multicenter Research Group: A placebo-controlled trial of captopril in refractory chronic heart failure. J Am Coll Cardiol 1983;2:755-763.
30. Hill JF, Bulpitt CJ, Fletcher AE: Angiotensin converting enzyme inhibitors and quality of life: The European Trial. J Hypertens 1985;9:S91-S94.
31. Packer M, Lee WH, Medina N, Yushak M, Kessler PD: Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure. Ann Intern Med 1987;106:346-354.
32. The CONSENSUS Trial Study Group: Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316: 1429-1435.
33. Pflugfelder PW, Baird MG, Tonkon MJ, Di Bianco R, Pitt B for the Quinapril Heart Failure Trial Investigators: Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. J Am Coll Cardiol 1993;23:1557-1563.
34. Cohn JN: Vasodilator therapy for heart failure: the influence of impedance on left ventricular performance. Circulation 1973;48:5-8.
35. The Captopril-Digoxin Multicenter Research Group: Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA 1988;259:539-375.
36. Packer M, Gheorghiade M, Young JB, et al.: for the RADIANCE Study Group: Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. N Engl J Med 1993; 329:1-7.
37. Kromer EP, Elsner D, Riegger GAJ: Digoxin, converting-enzyme inhibition (quinapril), and the combination in patients with congestive heart failure functional class II and sinus rhythm. J Cardiovasc Pharmacol 1990;16:9-14.
38. Vertes V, Haynie R: Comparative pharmacokinetics of captopril, enalapril, and quinapril. Am J Cardiol 1992; 69:8C-16C.
39. Nash DT: Comparative properties of angiotensin-converting enzyme inhibitors: relations with inhibition of tissue angiotensin-converting enzyme and potential clinical implications. Am J Cardiol 1992;69:26C-32C.
40. Unger T, Ganten D, Lang RE: Tissue converting enzymes and cardiovascular actions of converting enzyme inhibitors. J Cardiovasc Pharmacol 1986;8(Suppl 10):S75-S81.
41. Packer M, Lee WH, Medina N: Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure. Ann Intern Med 1987;106:346-354.